This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Infectious Disease Pharmacokinetics Laboratory" – news · newspapers · books · scholar · JSTOR (March 2012) (Learn how and when to remove this template message) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (March 2012) (Learn how and when to remove this template message) (Learn how and when to remove this template message)
Infectious Disease Pharmacokinetics Laboratory
TypeResearch/Clinical Laboratory
HeadquartersUniversity of Florida
Location
Director
Dr. Charles Peloquin
WebsiteOfficial website

The Infectious Disease Pharmacokinetics Laboratory (IDPL) is a research facility that is affiliated with the College of Pharmacy at the University of Florida.[1]

Overview

IDPL focuses on the treatments for infections that include HIV, tuberculosis, and other serious infections. This facility provides therapeutic drug monitoring (TDM) using high-performance liquid chromatography and gas chromatography. IDPL has been in existence for two decades and has developed individualized drug regimens by monitoring a patient's blood plasma or serum for target drug concentrations and then interpreting these results and advising physicians how to adjust a drug's dosage to achieve an optimal outcome. This interdisciplinary method allows IDPL to assess each patient's ability to absorb, metabolize and excrete drugs, which then enables them to recommend customized drug dosages based upon these pharmacokinetic factors as well as the severity of the patient's infection. IDPL primarily focuses on tuberculosis, but they also develop drug regimens for cancer patients with fungal infections, and people with HIV.

The Infectious Disease Pharmacokinetics Laboratory also serves as a national reference center for the determination of serum concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid.

Leadership

The director is Dr. Charles Peloquin who has been leading this facility for over 20 years. This facility is unique in that it provides finely detailed interpretations of results as applied to adjusting the drug regimens of individual patients. Dr. Peloquin's research efforts focuses on therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases.[1][2][3][4]

References

  1. ^ a b "Infectious Disease Pharmacokinetics Laboratory » College of Pharmacy » University of Florida".
  2. ^ "Emerging Pathogens Institute - University of Florida". www.epi.ufl.edu. 11 January 2024.
  3. ^ "Southeastern National Tuberculosis Center".
  4. ^ "Charles Peloquin » College of Pharmacy » University of Florida".

External links

University of Florida
Categories